TipRanks
Eastwood Bio-Medical Canada Inc (TSE:EBM)
:EBM
Canadian Market
Want to see TSE:EBM full AI Analyst Report?

Eastwood Bio-Medical Canada (EBM) Price & Analysis

5 Followers

EBM Stock Chart & Stats

C$1.85
C$0.01(1.02%)
At close: 4:00 PM EDT
C$1.85
C$0.01(1.02%)

Bulls Say, Bears Say

Bulls Say
Revenue GrowthSustained topline growth indicates improving demand and market activity. If maintained, expanding revenue can provide operating leverage and help the company absorb fixed costs as it scales.
Improved Cash GenerationThe move toward positive operating and free cash flow is an important improvement in financial quality. It may reduce reliance on external funding, although the current level remains modest and needs to prove durable.
Narrowing Losses And High Gross MarginA high gross margin provides a potentially attractive foundation for future profitability, while narrowing losses shows some progress. Better cost control or scale could allow more revenue to reach the bottom line over time.
Bears Say
Persistent Operating And Net LossesOngoing losses show that the current business scale and cost structure are not yet economically sustainable. Continued deficits can consume capital, restrict investment capacity, and make a durable path to profitability uncertain.
Negative Shareholders' EquityNegative equity materially weakens the capital structure and limits financial flexibility. It raises solvency and refinancing risk, while also reducing the company's ability to absorb setbacks or fund expansion without dilution or additional liabilities.
Unproven Cash Flow DurabilityAlthough cash flow recently turned slightly positive, the sharp period-to-period volatility and small scale relative to net losses make the improvement difficult to rely on. Sustained positive cash generation remains unproven.

EBM FAQ

What was Eastwood Bio-Medical Canada Inc’s price range in the past 12 months?
Eastwood Bio-Medical Canada Inc lowest stock price was C$0.34 and its highest was C$1.97 in the past 12 months.
    What is Eastwood Bio-Medical Canada Inc’s market cap?
    Eastwood Bio-Medical Canada Inc’s market cap is C$124.68M.
      When is Eastwood Bio-Medical Canada Inc’s upcoming earnings report date?
      Eastwood Bio-Medical Canada Inc’s upcoming earnings report date is Sep 24, 2026 which is in 3 days.
        How were Eastwood Bio-Medical Canada Inc’s earnings last quarter?
        Eastwood Bio-Medical Canada Inc released its earnings results on Jun 29, 2026. The company reported -C$0.001 earnings per share for the quarter.
          Is Eastwood Bio-Medical Canada Inc overvalued?
          According to Wall Street analysts Eastwood Bio-Medical Canada Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Eastwood Bio-Medical Canada Inc pay dividends?
            Eastwood Bio-Medical Canada Inc does not currently pay dividends.
            What is Eastwood Bio-Medical Canada Inc’s EPS estimate?
            Eastwood Bio-Medical Canada Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Eastwood Bio-Medical Canada Inc have?
            Eastwood Bio-Medical Canada Inc has 68,885,970 shares outstanding.
              What happened to Eastwood Bio-Medical Canada Inc’s price movement after its last earnings report?
              Eastwood Bio-Medical Canada Inc reported an EPS of -C$0.001 in its last earnings report. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Eastwood Bio-Medical Canada Inc?
                Currently, no hedge funds are holding shares in TSE:EBM
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Eastwood Bio-Medical Canada Inc

                  Eastwood Bio-Medical Canada Inc., established in Richmond, Canada, in 2010, is a company focused on the worldwide marketing and distribution of natural health products. Operating under the Eleotin brand, their offerings are available across Canada, the United States, and Asian regions. The firm's core mission is to deliver natural remedies for prevalent metabolic disorders, including issues with blood glucose regulation, hypertension, and obesity. Their extensive portfolio of licensed Eleotin products addresses diverse health requirements. For individuals experiencing spleen deficiency, appetite loss, or fatigue, Eleotin A 700 provides support. Eleotin AL88 serves as a laxative, while Eleotin Cal20 aids in the maintenance of healthy bones and teeth. Eleotin V3D is formulated for the development and upkeep of strong bones, teeth, and overall well-being. To support cardiovascular health, they offer Eleotin G2000. Eleotin H55 is designed to act as a sedative and alleviate tension, and Eleotin Zn330 is vital for tissue formation and metabolic processes. Furthermore, their product line includes Eleotin Bentley, which promotes balanced glucose levels, and Eleotin LBM, intended for hypertension relief.

                  Eastwood Bio-Medical Canada (EBM) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Arch Biopartners
                  Diagnos
                  Willow Biosciences Inc
                  ZYUS Life Sciences
                  Sona Nanotech Inc
                  Popular Stocks